Crossmark

Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1136/rmdopen-2018-000654

Published Online: 2018-04-09

Published Print: 2018-04

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Tweehuysen, Lieke

den Broeder, Nathan

van Herwaarden, Noortje

Joosten, Leo A B

van Lent, Peter L

Vogl, Thomas

van den Hoogen, Frank H J

Thurlings, Rogier M

den Broeder, Alfons A

Document is current

Any future updates will be listed below